- 
                Gov. Gavin Newsom has yet to make good on his promise of state-produced, affordable insulin for diabetics. What's the hold up?
 - 
                Oregon has the second fewest retail pharmacies per capita in the nation — with poorer access to pharmacies than any state except Alaska, according to a new analysis by the Associated Press.
 
- 
                        Poor data and coordination between regulatory agencies contribute to hospital drug thefts, experts say.
 - 
                        As Oregon moves closer to limiting prescription drug prices, the pharmaceutical industry has stepped up its efforts targeting the state board that could set those limits.
 - 
                        Oregon House Bill 4149 will regulate these middlemen in the drug market
 - 
                        To fight the skyrocketing cost of insulin, California is using multiple tactics, including making its own generic versions.
 - 
                        Bills would create new rules for pharmaceutical middlemen.
 - 
                        California plans to roll out an ambitious plan to manufacture its own insulin, but in the meantime, legislators are proposing to cap what diabetics pay.
 - 
                        It won’t surprise you to hear that getting a prescription filled in Oregon is getting more expensive each year. But according to a soon-to-be-released state report, drug price increases overall are getting fewer, and smaller.
 - 
                        The roughly $2 trillion House-passed measure awaits Senate action. The Senate majority leader says he'd like to try to finish by Christmas.
 - 
                        The price of many prescription drugs has been rising dramatically in recent years. This week, Oregonians will have a chance to give testimony about how those prices are affecting their ability to afford their medication.
 - 
                        Customers all around Oregon have reported standing in line for hours at pharmacies and waiting weeks for prescriptions to be filled. One reason for the wait times is staffing shortages.
 - 
                        In a ruling issued late Monday, state superior court Judge Peter J. Wilson found the companies, including Johnson & Johnson, aren't "legally liable" for the opioid crisis.
 - 
                        U.S. Senator Jeff Merkley of Oregon on Thursday introduced a bill that seeks to limit what he called price gouging for prescription drugs sold in the U.S.